However, several studies reported that KLF14 overexpression inhibited cell growth and proliferation in breast cancer (Chu et al., 2022), colorectal cancer (Li et al., 2020), and KRAS oncogenic mutant cancer cells (Fernandez‐Zapico et al., 2011). Here, KRAS is linked to breast cancer.